Investor Presentaiton slide image

Investor Presentaiton

SPECIALTY MIX Other IPD, 17.3% OPD, 11.9% Gynae, 4.1% Q3 FY23 Other Operating Revenue, 2.7% Cardiac, 18.3% Ortho, 8.4% Other IPD, 16.9% OPD, 13.5% Q3 FY24 Other Operating Revenue, 1.3% Cardiac, OO 17.6% - Ortho, 8.5% Renal, 7.4% Renal, 7.2% Gynae, 3.7% Pulmo, 3.1% Neuro, 8.7% Gastro, 5.1% Onco, 14.2% Pulmo, 2.9% Neuro, 8.4% Gastro, 4.6% Onco, 13.9% Specialties such as Gastroenterology, Pulmonology, Neuro Sciences, Oncology and Renal Sciences witnessed revenue growth of 21%, 17%, 14%, 13% and 13% respectively Fortis 18
View entire presentation